Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intraductal Carcinoma and Lobular Carcinoma in Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableWithdrawnNCT05032079
What this trial is testing

Subzero and Scorpion Trial

Who this might be right for
Ductal Carcinoma in Situ
Larkin Community Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT04084730
What this trial is testing

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Carcinoma, BreastDCIS+3 more
Memorial Sloan Kettering Cancer Center 280
Not applicableStudy completedNCT04866992
What this trial is testing

Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)

Who this might be right for
Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+9 more
University of Texas Southwestern Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT05941520
What this trial is testing

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Looking for participantsNCT06218303
What this trial is testing

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Who this might be right for
Ductal Carcinoma in Situ
Finn, Olivera, PhD 50
Not applicableStudy completedNCT06982313
What this trial is testing

Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms

Who this might be right for
Breast Cancer Invasive
Ente Ospedaliero Ospedali Galliera 1,545
Not applicableLooking for participantsNCT04169542
What this trial is testing

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Who this might be right for
Breast Ductal Carcinoma In SituCOVID-19 InfectionHereditary Breast Carcinoma+1 more
M.D. Anderson Cancer Center 600
Not applicableStudy completedNCT02370277
What this trial is testing

Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer+3 more
University of Southern California 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04176081
What this trial is testing

Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 208
Testing effectiveness (Phase 2)Study completedNCT01869764
What this trial is testing

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituMale Breast Cancer+6 more
Wake Forest University Health Sciences 57